Adamas Pharmaceuticals Inc. buy tamam
Start price
13.09.17
/
50%
€18.71
Target price
13.09.18
€37.88
Performance (%)
8.97%
End price
13.09.18
€20.39
Summary
This prediction ended on 13.09.18 with a price of €20.39. The BUY prediction by tamam finished with a performance of 8.97%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by tamam for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von klostergang zu
tamam stimmt am 13.09.2017 der Buy-Einschätzung von klostergang mit dem Kursziel 42$ zu.Überschrift: klostergang stimmt der Buy-Einschätzung von klostergang zu
(Laufzeit überschritten)
Stopped prediction by tamam for Adamas Pharmaceuticals Inc.
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.46
17.12.19
17.12.19
€6.00
04.11.21
04.11.21
103.76%
05.11.21
05.11.21
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.43
15.09.18
15.09.18
€10.00
17.12.19
17.12.19
-82.19%
17.12.19
17.12.19